Lannett Co Inc (LCI) 46.88 $LCI
Merck KGaA Q3 Earnings Rise Y/Y, 2014 View Upgraded - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 1:20PM CST
Merck KGaA (MKGAF) reported third-quarter 2014 earnings of $1.53 per American Depositary Receipt (ADR), up 0.2% from the year-ago quarter.
LCI: 46.88 (-1.40), VRX: 134.21 (+2.31), ADHD: 3.66 (+0.06)
Flamel Technologies (FLML) in Focus: Stock Rises 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 8:46AM CST
Flamel Technologies (FLML) was a big mover last session, with shares rising just over 11% on the day.
LCI: 46.88 (-1.40), FLML: 13.17 (-0.22), ADHD: 3.66 (+0.06), SCMP: 11.30 (+0.20)
Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:25AM CST
Sucampo Pharmaceuticals (SCMP) was a big mover last session, with shares rising over 7% on the day.
LCI: 46.88 (-1.40), SHPG: 202.62 (+0.20), SCMP: 11.30 (+0.20), CEMP: 13.60 (-0.56)
Avanir Faces Regulatory Setback, AVP-825 Could Be Delayed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 4:40PM CST
Avanir Pharmaceuticals, Inc. (AVNR) received a disappointing preliminary feedback from the FDA regarding its new drug application for AVP-825.
LCI: 46.88 (-1.40), AVNR: 13.13 (-0.01), AUXL: 32.17 (-0.18), GSK: 45.74 (+0.08)
UCB to Sell Generics Business, Focus on Core Segments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 4:30PM CST
UCB SA (UCBJF) entered into an agreement with Advent International and Avista Capital Partners for the sale of its specialty generics subsidiary for $1.525 billion.
LCI: 46.88 (-1.40), LLY: 67.33 (-0.35), GSK: 45.74 (+0.08), NVS: 93.95 (-0.43)
Stocks Rise; IBD 50 Stocks Lead The Way
at Investor's Business Daily - Mon Nov 10, 3:32PM CST
The stock market finished higher Monday, with no major news and a smattering of morning earnings reports. Volume ran lighter than Friday, according to preliminary data. The Nasdaq rose 0.4%; the S&P 500 gained 0.3% and the Dow Jones industrial...
AMBA: 47.84 (+0.10), WWAV: 36.56 (+0.42), BCC: 37.03 (-0.16), LCI: 46.88 (-1.40), BIDU: 249.70 (+5.61), DF: 16.61 (-0.06)
La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:44AM CST
La Jolla Pharmaceutical Co. (LJPC) was a big mover last session, as the company saw its shares surge over 10% on the day
ENDP: 66.26 (-0.84), LCI: 46.88 (-1.40), BCRX: 10.07 (-0.32), LJPC: 11.06 (unch)
Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 37.03 (-0.16), LCI: 46.88 (-1.40), AKRX: 38.21 (+0.53), AFSI: 52.48 (+0.32), EXPE: 87.93 (+1.44), FFIV: 128.88 (+2.73), SLXP: 102.32 (+5.33), MPWR: 45.46 (+0.59), TMH: 54.48 (+0.57), ATHM: 44.58 (+1.59)
Update: Lannett Fiscal Q1 2015 Earnings
ONeil Trader - at Seeking Alpha - Thu Nov 06, 1:13AM CST
LCI: 46.88 (-1.40)
Let Major Indexes Dictate Buy, Sell Decisions
at Investor's Business Daily - Wed Nov 05, 5:01PM CST
The S&P 500 and Nasdaq composite serve as guideposts to the market's health. Ignore them at your own peril. Every day, IBD analyzes the action of these major stock averages to determine whether the market is in an uptrend (healthy) or a correction...
LCI: 46.88 (-1.40), AKRX: 38.21 (+0.53), ORLY: 179.88 (-1.75), AFSI: 52.48 (+0.32), CELG: 104.05 (-3.38)
Stocks Narrow Losses; Airlines Lead
at Investor's Business Daily - Tue Nov 04, 12:29PM CST
Stocks narrowed losses near midday Tuesday, but some leaders remained under pressure. The Nasdaq fell 0.6%, the S&P 500 dropped 0.4%, and the Dow Jones industrial average was down a fraction. Wal-Mart Stores (WMT), Travelers (TRV) and Procter &...
LCI: 46.88 (-1.40), SAVE: 76.15 (-1.95), WMT: 82.96 (+0.02), PG: 88.11 (-0.49), ATHM: 44.58 (+1.59), TXRH: 31.86 (-0.57), LUV: 38.95 (-0.51), TRV: 102.43 (-0.80)
Insider Trading Alert - LGF, OMI And LCI Traded By Insiders
at The Street - Tue Nov 04, 10:35AM CST
Stocks with insider trader activity include LGF, OMI and LCI
LCI: 46.88 (-1.40), LGF: 35.11 (-0.11), OMI: 33.74 (-0.27)
Lannett's (LCI) CEO Arthur Bedrosian on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 03, 10:22PM CST
LCI: 46.88 (-1.40)
Lannett ups revenue outlook
at Investor's Business Daily - Mon Nov 03, 5:26PM CST
The generic-drug maker's adjusted EPS skyrocketed 327% to 94 cents in Q1 '15, passing views by 10 cents. Revenue soared 104% to $93.4 mil, topping expectations for $91.9 mil. Lannett (LCI) raised its full-year '15 revenue range by $20 mil, to $370...
LCI: 46.88 (-1.40)
Sprint, RetailMeNot Disappoint The Street After Hours
at Investor's Business Daily - Mon Nov 03, 3:57PM CST
Stocks finished mixed Monday, with volume lower across the board. Oil dropped more than $2 a barrel and was trading near $78. After the close, wireless carrier Sprint (S) dropped sharply after announcing disappointing Q4 results. It reported a loss...
LCI: 46.88 (-1.40), S: 5.05 (+0.05), JAZZ: 174.57 (+1.59), SALE: 15.03 (+0.34), KORS: 72.06 (+1.32), PCLN: 1,172.96 (+4.95), BABA: 115.10 (+0.26)
Lannett beats by $0.10, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 3:09PM CST
LCI: 46.88 (-1.40)
Lannett Reports Net Sales of $93 Million, EPS of $0.94 for Fiscal 2015 First Quarter
Business Wire - Mon Nov 03, 3:05PM CST
Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2015 first quarter ended September 30, 2014.
LCI: 46.88 (-1.40)
Stocks Open Mixed And Quiet; Chipmakers In Motion
at Investor's Business Daily - Mon Nov 03, 9:35AM CST
Stocks wobbled in a mixed start Monday on a cross-current of company news and economic reports. The Nasdaq climbed 0.3% and the Dow Jones industrial average dipped 0.1%, but both moved in soft trade. The S&P 500 added a fraction. Volume was weak on...
AMBA: 47.84 (+0.10), LCI: 46.88 (-1.40), MU: 32.62 (-0.32), SWKS: 62.80 (+2.09), SAPE: 24.68 (unch), AFSI: 52.48 (+0.32), CRUS: 19.15 (+0.13), LH: 98.84 (-0.72), CVD: 100.30 (-0.23)
Lannett Announces Positive FDA Inspection Results
Business Wire - Mon Nov 03, 6:54AM CST
Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has completed its cGMP compliance inspection of Lannett's wholly owned subsidiary Cody Laboratories, Inc. (Cody), a manufacturer of active pharmaceutical ingredients (APIs) and finished dosage form products. The inspection commenced on Monday, October 27, 2014, and was completed on Thursday, October 30, 2014.
LCI: 46.88 (-1.40)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:35PM CST
RKT: 55.60 (-0.27), HLF: 38.50 (+0.65), EGAN: 5.19 (-0.19), CUTR: 10.53 (+0.19), DXPE: 65.54 (-1.19), AEIS: 20.64 (+0.11), NOR: 3.90 (-0.06), KBR: 18.85 (+0.12), SGY: 22.90 (+1.04), RTEC: 9.16 (+0.07), PKT: 7.10 (+0.05), OGS: 38.13 (+0.15), BKH: 53.89 (-0.53), KAMN: 40.86 (-0.27), EOX: 2.76 (+0.06), MR: 31.06 (-0.16), RKUS: 12.32 (+0.23), LCI: 46.88 (-1.40), NBIX: 18.92 (-0.22), PQ: 4.12 (+0.17), RBC: 71.12 (-0.03), CHGG: 6.90 (+0.04), AIG: 53.90 (-0.60), MRO: 32.36 (+0.41), GRT: 13.84 (-0.02), EPAM: 49.64 (+0.47), CKP: 12.70 (-0.14), SBRA: 27.12 (-0.53), MDU: 25.09 (+0.09), NTRI: 18.36 (-0.14), ELNK: 4.22 (+0.04), EQC: 25.60 (-0.33), CVD: 100.30 (-0.23), IART: 47.64 (-0.47), FN: 17.81 (+0.31), APL: 33.13 (+0.13), BDE: 8.81 (-0.09), AGU: 100.28 (+0.52), PLOW: 23.18 (+0.22), REG: 60.74 (-0.70), QLYS: 36.63 (+0.96), GALE: 1.87 (-0.01), ANV: 1.37 (+0.17), ININ: 47.97 (+1.02), FTR: 6.81 (+0.08), GTY: 18.25 (-0.17), MCEP: 16.17 (-0.64), CYH: 45.11 (-1.09), SKH: 7.10 (+0.05), ACXM: 18.56 (+0.03), PL: 69.70 (-0.18), RLD: 11.52 (-0.03), CXW: 36.00 (-0.15), SALE: 15.03 (+0.34), ENH: 57.67 (-0.10), CRK: 11.81 (+0.44), AMTG: 16.26 (+0.05), OTTR: 29.17 (-0.22), NLS: 14.53 (+0.25)
Merck KGaA Q3 Earnings Rise Y/Y, 2014 View Upgraded - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 1:20PM CST
Merck KGaA (MKGAF) reported third-quarter 2014 earnings of $1.53 per American Depositary Receipt (ADR), up 0.2% from the year-ago quarter.
LCI: 46.88 (-1.40), VRX: 134.21 (+2.31), ADHD: 3.66 (+0.06)
Flamel Technologies (FLML) in Focus: Stock Rises 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 8:46AM CST
Flamel Technologies (FLML) was a big mover last session, with shares rising just over 11% on the day.
LCI: 46.88 (-1.40), FLML: 13.17 (-0.22), ADHD: 3.66 (+0.06), SCMP: 11.30 (+0.20)
Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:25AM CST
Sucampo Pharmaceuticals (SCMP) was a big mover last session, with shares rising over 7% on the day.
LCI: 46.88 (-1.40), SHPG: 202.62 (+0.20), SCMP: 11.30 (+0.20), CEMP: 13.60 (-0.56)
Avanir Faces Regulatory Setback, AVP-825 Could Be Delayed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 4:40PM CST
Avanir Pharmaceuticals, Inc. (AVNR) received a disappointing preliminary feedback from the FDA regarding its new drug application for AVP-825.
LCI: 46.88 (-1.40), AVNR: 13.13 (-0.01), AUXL: 32.17 (-0.18), GSK: 45.74 (+0.08)
UCB to Sell Generics Business, Focus on Core Segments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 4:30PM CST
UCB SA (UCBJF) entered into an agreement with Advent International and Avista Capital Partners for the sale of its specialty generics subsidiary for $1.525 billion.
LCI: 46.88 (-1.40), LLY: 67.33 (-0.35), GSK: 45.74 (+0.08), NVS: 93.95 (-0.43)
Stocks Rise; IBD 50 Stocks Lead The Way
at Investor's Business Daily - Mon Nov 10, 3:32PM CST
The stock market finished higher Monday, with no major news and a smattering of morning earnings reports. Volume ran lighter than Friday, according to preliminary data. The Nasdaq rose 0.4%; the S&P 500 gained 0.3% and the Dow Jones industrial...
AMBA: 47.84 (+0.10), WWAV: 36.56 (+0.42), BCC: 37.03 (-0.16), LCI: 46.88 (-1.40), BIDU: 249.70 (+5.61), DF: 16.61 (-0.06)
La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:44AM CST
La Jolla Pharmaceutical Co. (LJPC) was a big mover last session, as the company saw its shares surge over 10% on the day
ENDP: 66.26 (-0.84), LCI: 46.88 (-1.40), BCRX: 10.07 (-0.32), LJPC: 11.06 (unch)
Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 37.03 (-0.16), LCI: 46.88 (-1.40), AKRX: 38.21 (+0.53), AFSI: 52.48 (+0.32), EXPE: 87.93 (+1.44), FFIV: 128.88 (+2.73), SLXP: 102.32 (+5.33), MPWR: 45.46 (+0.59), TMH: 54.48 (+0.57), ATHM: 44.58 (+1.59)
Update: Lannett Fiscal Q1 2015 Earnings
ONeil Trader - at Seeking Alpha - Thu Nov 06, 1:13AM CST
LCI: 46.88 (-1.40)
Let Major Indexes Dictate Buy, Sell Decisions
at Investor's Business Daily - Wed Nov 05, 5:01PM CST
The S&P 500 and Nasdaq composite serve as guideposts to the market's health. Ignore them at your own peril. Every day, IBD analyzes the action of these major stock averages to determine whether the market is in an uptrend (healthy) or a correction...
LCI: 46.88 (-1.40), AKRX: 38.21 (+0.53), ORLY: 179.88 (-1.75), AFSI: 52.48 (+0.32), CELG: 104.05 (-3.38)
Stocks Narrow Losses; Airlines Lead
at Investor's Business Daily - Tue Nov 04, 12:29PM CST
Stocks narrowed losses near midday Tuesday, but some leaders remained under pressure. The Nasdaq fell 0.6%, the S&P 500 dropped 0.4%, and the Dow Jones industrial average was down a fraction. Wal-Mart Stores (WMT), Travelers (TRV) and Procter &...
LCI: 46.88 (-1.40), SAVE: 76.15 (-1.95), WMT: 82.96 (+0.02), PG: 88.11 (-0.49), ATHM: 44.58 (+1.59), TXRH: 31.86 (-0.57), LUV: 38.95 (-0.51), TRV: 102.43 (-0.80)
Insider Trading Alert - LGF, OMI And LCI Traded By Insiders
at The Street - Tue Nov 04, 10:35AM CST
Stocks with insider trader activity include LGF, OMI and LCI
LCI: 46.88 (-1.40), LGF: 35.11 (-0.11), OMI: 33.74 (-0.27)
Lannett's (LCI) CEO Arthur Bedrosian on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 03, 10:22PM CST
LCI: 46.88 (-1.40)
Lannett ups revenue outlook
at Investor's Business Daily - Mon Nov 03, 5:26PM CST
The generic-drug maker's adjusted EPS skyrocketed 327% to 94 cents in Q1 '15, passing views by 10 cents. Revenue soared 104% to $93.4 mil, topping expectations for $91.9 mil. Lannett (LCI) raised its full-year '15 revenue range by $20 mil, to $370...
LCI: 46.88 (-1.40)
Sprint, RetailMeNot Disappoint The Street After Hours
at Investor's Business Daily - Mon Nov 03, 3:57PM CST
Stocks finished mixed Monday, with volume lower across the board. Oil dropped more than $2 a barrel and was trading near $78. After the close, wireless carrier Sprint (S) dropped sharply after announcing disappointing Q4 results. It reported a loss...
LCI: 46.88 (-1.40), S: 5.05 (+0.05), JAZZ: 174.57 (+1.59), SALE: 15.03 (+0.34), KORS: 72.06 (+1.32), PCLN: 1,172.96 (+4.95), BABA: 115.10 (+0.26)
Lannett beats by $0.10, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 3:09PM CST
LCI: 46.88 (-1.40)
Lannett Reports Net Sales of $93 Million, EPS of $0.94 for Fiscal 2015 First Quarter
Business Wire - Mon Nov 03, 3:05PM CST
Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2015 first quarter ended September 30, 2014.
LCI: 46.88 (-1.40)
Stocks Open Mixed And Quiet; Chipmakers In Motion
at Investor's Business Daily - Mon Nov 03, 9:35AM CST
Stocks wobbled in a mixed start Monday on a cross-current of company news and economic reports. The Nasdaq climbed 0.3% and the Dow Jones industrial average dipped 0.1%, but both moved in soft trade. The S&P 500 added a fraction. Volume was weak on...
AMBA: 47.84 (+0.10), LCI: 46.88 (-1.40), MU: 32.62 (-0.32), SWKS: 62.80 (+2.09), SAPE: 24.68 (unch), AFSI: 52.48 (+0.32), CRUS: 19.15 (+0.13), LH: 98.84 (-0.72), CVD: 100.30 (-0.23)
Lannett Announces Positive FDA Inspection Results
Business Wire - Mon Nov 03, 6:54AM CST
Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has completed its cGMP compliance inspection of Lannett's wholly owned subsidiary Cody Laboratories, Inc. (Cody), a manufacturer of active pharmaceutical ingredients (APIs) and finished dosage form products. The inspection commenced on Monday, October 27, 2014, and was completed on Thursday, October 30, 2014.
LCI: 46.88 (-1.40)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:35PM CST
RKT: 55.60 (-0.27), HLF: 38.50 (+0.65), EGAN: 5.19 (-0.19), CUTR: 10.53 (+0.19), DXPE: 65.54 (-1.19), AEIS: 20.64 (+0.11), NOR: 3.90 (-0.06), KBR: 18.85 (+0.12), SGY: 22.90 (+1.04), RTEC: 9.16 (+0.07), PKT: 7.10 (+0.05), OGS: 38.13 (+0.15), BKH: 53.89 (-0.53), KAMN: 40.86 (-0.27), EOX: 2.76 (+0.06), MR: 31.06 (-0.16), RKUS: 12.32 (+0.23), LCI: 46.88 (-1.40), NBIX: 18.92 (-0.22), PQ: 4.12 (+0.17), RBC: 71.12 (-0.03), CHGG: 6.90 (+0.04), AIG: 53.90 (-0.60), MRO: 32.36 (+0.41), GRT: 13.84 (-0.02), EPAM: 49.64 (+0.47), CKP: 12.70 (-0.14), SBRA: 27.12 (-0.53), MDU: 25.09 (+0.09), NTRI: 18.36 (-0.14), ELNK: 4.22 (+0.04), EQC: 25.60 (-0.33), CVD: 100.30 (-0.23), IART: 47.64 (-0.47), FN: 17.81 (+0.31), APL: 33.13 (+0.13), BDE: 8.81 (-0.09), AGU: 100.28 (+0.52), PLOW: 23.18 (+0.22), REG: 60.74 (-0.70), QLYS: 36.63 (+0.96), GALE: 1.87 (-0.01), ANV: 1.37 (+0.17), ININ: 47.97 (+1.02), FTR: 6.81 (+0.08), GTY: 18.25 (-0.17), MCEP: 16.17 (-0.64), CYH: 45.11 (-1.09), SKH: 7.10 (+0.05), ACXM: 18.56 (+0.03), PL: 69.70 (-0.18), RLD: 11.52 (-0.03), CXW: 36.00 (-0.15), SALE: 15.03 (+0.34), ENH: 57.67 (-0.10), CRK: 11.81 (+0.44), AMTG: 16.26 (+0.05), OTTR: 29.17 (-0.22), NLS: 14.53 (+0.25)
